Fedora Pharmaceuticals Inc.
$245,000.00 CAD
≈ 3 Canadians' average pay for a year
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2018-2019
- Agreement period
- April 1, 2018 – March 31, 2020
- Reference
- nrc-cnrc:172-2018-2019-Q4-898980
Published purpose
Antimicrobial resistance bacteria (AMR) have a significant impact on mortality, hospital stay and associated costs. The overall objectives of the project are to prepare new oral antibiotics capable of killing AMR and treating serious and life-threatening infections in patients.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 3, 2026 from open.canada.ca Grants & Contributions